Search

Your search keyword '"Antiviral agents -- Product introduction"' showing total 32 results
Start Over Descriptor "Antiviral agents -- Product introduction" Topic pharmaceuticals and cosmetics industries
32 results on '"Antiviral agents -- Product introduction"'

1. Selected new drugs of 1996

Author

Hussar, Daniel A.

Subjects
Antiviral agents -- Product introduction, Anti-infective agents -- Product introduction, Hypoglycemic agents -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Health care industry, Retail industry, Product introduction
Abstract

A review of agents that treat HIV, infection, diabetes and ALS In this second part of a two-part series on selected new drugs that have been marketed in 1996, the [...]

Published
1996

2. FDA approves addition of new warnings to hep C drug label

Author

Talsma, Julia

Subjects
Antiviral agents -- Product introduction, Simeprevir -- Product introduction, Business, Pharmaceuticals and cosmetics industries
Abstract

FDA has approved label changes for the hepatitis C antiviral simeprevir (Olysio; Janssen) that will include new warnings about serious symptomatic bradycardia--slowing of the heart rate--when the drug is coadministered [...]

Published
2015

3. Clinical News: Treatment launched for hepatitis

Subjects
Novartis Pharma AG -- Product introduction, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Hepatitis B -- Drug therapy, Chemicals, plastics and rubber industries, Pharmaceuticals and cosmetics industries, Sebivo (Medication) -- Product introduction
Abstract

Novartis Pharmaceuticals has launched a treatments for hepatitis B. Telbivudine (Sebivo) is licensed for the treatment of chronic hepatitis B in adults with compensated liver disease, evidence of viral replication, [...]

Published
2007

4. OVER THE COUNTER: New prescription product - Emtriva oral solution

Subjects
Gilead Sciences Inc. -- Product introduction, Biological products industry -- Product introduction, Anti-HIV agents -- Product introduction, Antiviral agents -- Product introduction, Chemicals, plastics and rubber industries, Pharmaceuticals and cosmetics industries
Abstract

Liquid containing emtricitabine 10mg/ml For use in HIV-1 infections or in combination with other anti- retrovirals Usual dose: 240mg (24ml) once daily in adults and 6mg/kg (up to 240mg) in [...]

Published
2005

5. Telzir Oral Suspension

Subjects
GlaxoSmithKline PLC -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Chemicals, plastics and rubber industries, Pharmaceuticals and cosmetics industries
Abstract

GlaxoSmithKline has launched Telzir (fosamprenavir) 50mg/ml Oral Suspension. It is licensed in combination with low dose ritonavir for the treatment of HIV in adults over 18 years old. It should [...]

Published
2004

6. Emtriva for HIV

Subjects
Gilead Sciences Inc. -- Product introduction, AIDS patients -- Drug therapy, Antiviral agents -- Product introduction, Chemicals, plastics and rubber industries, Pharmaceuticals and cosmetics industries, Emtriva (Medication) -- Product introduction
Abstract

Gilead has launched a new nucleoside and nucleotide reverse transcriptase inhibitor for the treatment of HIV-1 infected adults and children in conjunction with other antiretroviral agents. Emtriva (emtricitabine 200mg capsules) [...]

Published
2003

7. NEW DRUGS

Subjects
United States. Food and Drug Administration -- Laws, regulations and rules, Organon Inc. -- Product introduction -- Laws, regulations and rules, Salix Pharmaceuticals -- Product introduction, Axcan Scandipharm Inc. -- Product introduction, Schering-Plough Corp. -- Product introduction -- Laws, regulations and rules, Enzon Pharmaceuticals Inc. -- Product introduction -- Laws, regulations and rules, Hepatitis -- Laws, regulations and rules, Antiviral agents -- Product introduction, Contraceptives industry -- Product introduction, Pharmaceutical industry -- Product introduction, Oral contraceptives -- Product introduction, Government regulation, Business, Pharmaceuticals and cosmetics industries, Cyclessa (Contraceptive) -- Product introduction, Colazal (Medication) -- Product introduction, Canasa (Medication) -- Product introduction, Peg-Intron (Medication) -- Product introduction
Abstract

Organon Inc., West Orange, N.J., (800) 241-8812, has received FDA approval for Cyclessa (desogestrel/ethinyl estradiol oral contraceptive), the first low-dose (less than 30 mcg of estrogen) triphasic contraceptive. Cyclessa is [...]

Published
2001

8. New drugs of 1986

Author

Hussar, Daniel A.

Subjects
Drugs -- Product introduction, Pharmaceutical industry -- Product introduction, Pediculosis -- Care and treatment, Antiviral agents -- Product introduction, Anti-arrhythmia drugs -- Product introduction, New products -- Analysis, Business, Health care industry, Pharmaceuticals and cosmetics industries, Retail industry
Published
1986

9. New products in 1994

Author

Hughes, Susan

Subjects
Genentech Inc. -- Product introduction, Roche Holding Ltd. -- Product introduction, Pfizer Inc. -- Product introduction, Upjohn Co. -- Product introduction, Hoechst AG -- Product introduction, Cystic fibrosis -- Drug therapy, Rheumatoid arthritis -- Drug therapy, Subarachnoid hemorrhage -- Drug therapy, Antidepressants -- Product introduction, Alzheimer's disease -- Drug therapy, Antiviral agents -- Product introduction, Immunosuppressive agents -- Product introduction, Antineoplastic agents -- Product introduction, Cardiovascular agents -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Pulmozyme (Medication) -- Product introduction, Tenidap (Medication) -- Product introduction, Freedox (Medication) -- Product introduction, Velnacrine (Medication) -- Product introduction
Published
1994

10. Reese rollout

Subjects
Reese Pharmaceutical Co. -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Retail industry, OneTab (Medication) -- Product introduction
Abstract

Reese Pharmaceutical Co. has introduced a line of three O-T-C dye-flee cold- and flu-relief tablet products. Marketed under the brand name OneTab, the individual product offerings are for cold and [...]

Published
2009

11. Roche says that supplies of Tamiflu are adequate

Subjects
Hoffmann-La Roche Inc. -- Product introduction -- Company forecasts, Antiviral agents -- Product introduction, Pharmaceutical industry -- Company forecasts -- Product introduction, Company business forecast/projection, Business, Pharmaceuticals and cosmetics industries, Retail industry
Abstract

Hoffman-La Roche Inc. asserts that its Tamiflu antiviral flu medication will be in ample supply for the 2008/09 flu season. The product, known by its generic name of oseltamivir phosphate, [...]

Published
2008

12. Roche

Subjects
Roche Holding AG -- Product introduction, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Retail industry, Tamiflu (Medication) -- Product introduction
Abstract

Ample supplies of the flu medication Tamiflu will be available throughout the United States during flu season, manufacturer Roche stated. The Centers for Disease Control and Prevention has cited Tamiflu [...]

Published
2008

13. Abbott urged to provide new version of Kaletra to poor countries

Subjects
Abbott Laboratories (Abbott Park, Illinois) -- Product enhancement, Abbott Laboratories (Abbott Park, Illinois) -- International marketing, Alternative medicine -- International marketing, Antiviral agents -- Product introduction, Antiviral agents -- International marketing, Pharmaceutical industry -- Product introduction, Pharmaceutical industry -- International marketing, Product enhancement, Business, Pharmaceuticals and cosmetics industries
Abstract

A non-governmental organization, Medecins sans Frontieres, has asked Abbott Laboratories to introduce a new version of its antiretroviral drug, Kaletra (lopinavir plus ritonavir) for sale in poor and developing countries.

Published
2006

14. PS debut

Subjects
Antibacterial agents -- Product introduction, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Retail industry
Abstract

American HomeHealth Inc. has created an 'infection prevention' category with its debut of PS. The brand incorporates a number of antiviral and antibacterial products to help consumers with their cleaning [...]

Published
2006

15. Geneva Pharmaceuticals

Author

Frederick, James

Subjects
Geneva Pharmaceuticals Inc. -- Product introduction, Hepatitis C -- Care and treatment, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Retail industry
Abstract

Last month, Geneva Pharmaceuticals announced that it is moving ahead with its generic production of Schering-Plough's Rebetol (ribavirin), a hepatitis C treatment that generated $721 million in sales for the [...]

Published
2003

16. Ranbaxy launches abacavir in India

Subjects
Ranbaxy Laboratories Ltd. -- Product introduction, Ranbaxy Laboratories Ltd. -- Product information, Pharmaceutical industry -- Product information, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Antiviral agents -- Product information, Business, Pharmaceuticals and cosmetics industries
Abstract

Ranbaxy Laboratories' abacavir antiretroviral drug has been launched in India. The drug is marketed under the Virol brand name. It is the generic version of GlaxoSmithKline's Ziagen drug.

Published
2003

17. More generic drugs wanted by Thailand

Subjects
Abbott Laboratories (Abbott Park, Illinois) -- Product introduction, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Pharmaceuticals and cosmetics industries
Abstract

In response to the decision by US drugmaker Abbott Laboratories to boycott Thailand's market for new drugs, itself a reaction to an earlier government decision to issue compulsory licenses against [...]

Published
2007

18. GSK moves to help poorest fight HIV/AIDS

Subjects
GSK PLC -- Product introduction -- Services, Antiviral agents -- Product introduction, Drugs -- Prices and rates -- Services -- Product introduction, Pharmaceutical industry -- Product introduction -- Services, Company pricing policy, Pharmaceuticals and cosmetics industries, World Health Organization -- Services, Ziagen (Medication) -- Product introduction -- Prices and rates
Abstract

UK-based GlaxoSmithKline, the world's second-largest drugmaker, has announced further action to help the world's poorest countries meet the unique challenges of HIV/AIDS. In keeping with its commitment to pass on [...]

Published
2006

19. Open BioSystems debuts Lentiviral shRNAmir library

Subjects
Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Pharmaceuticals and cosmetics industries
Abstract

Open Biosystems, a US firm focused on the commercialization of leading-edge life science research tools for drug discovery, has announced the availability of its lentiviral microRNA-adapted short hairpin RNA (shRNAmir) [...]

Published
2006

20. Ranbaxy India launches high compliance ARVs

Subjects
Ranbaxy Laboratories Ltd. -- Product introduction, Antiviral agents -- Product introduction, Anti-HIV agents -- Product introduction, Pharmaceutical industry -- Product introduction, Pharmaceuticals and cosmetics industries, Virolis-E (Medication) -- Product introduction
Abstract

Indian drugs giant Ranbaxy Laboratories has introduced two new anti-HIV products, Virolis-E and Virocomb-E. Both products contain three anti-retroviral drugs and offer World Health Organization-recommended first-line highly-active anti-retroviral Therapy in [...]

Published
2005

21. 1st launch of B Ingelheim's nevirapine

Subjects
Boehringer Ingelheim GmbH -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Viramune (Medication) -- Product introduction
Published
1996

22. UK launch of oral ganciclovir

Subjects
Roche Holding Ltd. -- Product introduction -- 00401302, Pharmaceutical industry -- Product introduction, Cytomegalovirus infections -- Drug therapy, Antiviral agents -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Cymevene (Medication) -- Product introduction
Published
1995

23. Gilead's new antivirals

Subjects
Gilead Sciences Inc. -- Product introduction -- 00223651, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Business, Pharmaceuticals and cosmetics industries
Published
1995

24. First launches of Wellcome's Valtrex

Subjects
Wellcome PLC -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Shingles (Disease), Business, Pharmaceuticals and cosmetics industries, Valtrex (Medication) -- Product introduction
Published
1995

25. Famvir's launch in the US

Subjects
SmithKline Beecham Corp. -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Famvir (Medication) -- Product introduction
Published
1994

26. Ciba launches trifluridine in Italy

Subjects
Italy -- Health aspects, Ciba Vision Corp. -- Product introduction, Antiviral agents -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Triherpine (Medication) -- Product introduction
Published
1994

27. 1st launch for SB's famciclovir - the UK

Subjects
United Kingdom -- Health aspects, SmithKline Beecham Corp. -- Product introduction, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Shingles (Disease), Business, Pharmaceuticals and cosmetics industries, Famvir (Medication) -- Product introduction
Published
1994

28. Videx launched in Japan

Subjects
Bristol-Myers Squibb Co. -- Product introduction, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Videx (Medication) -- Product introduction
Published
1992

29. Mochida launches vidarabine for herpes in Japan

Subjects
Mochida Pharmaceutical Company Ltd. -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Arasena-A (Medication) -- Product introduction
Published
1992

30. Schering - pinning its hopes on MS drug

Subjects
Bayer HealthCare Pharmaceuticals -- Product introduction, Antiviral agents -- Product introduction, Multiple sclerosis -- Care and treatment, Business, Business, international, Pharmaceuticals and cosmetics industries
Abstract

Schering expects 20 million US dollar sales in 1993 from Betaseron, a beta interferon targeted at the treatment of relapsing-remitting multiple sclerosis (MS). For 1994, sales of 200 million US dollars are forecast. The product received FDA approval in July 1993, and it hit the US market in October of the same year. The company plans to invest 860 million Deutsche Marks (DM) in 1994 on R&D, compared to DM800 million in 1993.

Published
1993

31. Hepatitis A vaccine - licence potential?

Subjects
Pasteur Merieux Serums et Vaccins S.A. -- Product introduction, Pharmaceutical industry -- Product introduction, Hepatitis A -- Drug therapy, Vaccines -- Product introduction, Antiviral agents -- Product introduction, Business, Business, international, Pharmaceuticals and cosmetics industries, Avaxim (Medication) -- Product introduction
Abstract

Pharmaceutical joint venture Pasteur Merieux has launched its Avaxin hepatitis A vaccine in the U.K.. The company had been expected to introduce Vaqta, which has received licenses in the U.S. and Germany. Pasteur Merieux's director of business relations says that the two vaccines are very similar.

Published
1996

32. Wellcome launches successor to ageing blockbuster Zovirax

Subjects
Wellcome PLC -- Product introduction, Antiviral agents -- Product introduction, Business, Business, international, Pharmaceuticals and cosmetics industries
Abstract

Wellcome UK has introduced Valtrex, a new antiviral drug and a development of its Zovirax antiviral agent. Valtrex will treat herpes zoster and the company hopes the drug will help it maintain its major share of the antiviral. Valtrex is said to resolve acute shingles pain faster than Zovirax and it has improved bioavailability.

Published
1995

Catalog

Books, media, physical & digital resources
See catalog results